Ignite Creation Date:
2024-05-05 @ 11:10 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01275248
Status:
TERMINATED
Last Update Posted:
2013-01-18
First Post:
2011-01-10
Brief Title:
Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder
Sponsor:
Transcept Pharmaceuticals
Organization:
Transcept Pharmaceuticals